N

ENDRA Life Sciences
D

NDRA

5.99000
USD
0.23
(3.99%)
Market Closed
Volume
200
EPS
-717
Div Yield
-
P/E
-0
Market Cap
3,216,079
OverviewSignalsIdeasNews
Related Instruments
    A
    ATHX
    0.00290
    (2.96%)
    0.10100 USD
    C
    CAPR
    0.100
    (0.54%)
    18.620 USD
    C
    CERS
    -0.07500
    (-4.18%)
    1.72000 USD
    D
    DRRX
    -0.12820
    (-11.45%)
    0.99180 USD
    I
    IMGN
    0
    (0%)
    0.000000 USD
    K
    KPTI
    -0.02960
    (-3.54%)
    0.80740 USD
    M
    MRKR
    -0.63000
    (-17.21%)
    3.03000 USD
    O
    OCUL
    -0.77000
    (-7.75%)
    9.16000 USD
    X
    XOMA
    0.590
    (1.98%)
    30.460 USD
    More
News

Title: ENDRA Life Sciences Inc

Sector: Healthcare
Industry: Diagnostics & Research
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH),chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.